Twist Bioscience Corporation TWST Operating Income
Operating Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Twist Bioscience Corporation in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Twist Bioscience Corporation's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Twist Bioscience Corporation's operating income?
- Twist Bioscience Corporation (TWST) reported operating income of -$45.86M in Q1 2026.
- How has Twist Bioscience Corporation's operating income changed year-over-year?
- Twist Bioscience Corporation's operating income decreased by 10.4% year-over-year, from -$41.56M to -$45.86M.
- What is the long-term trend for Twist Bioscience Corporation's operating income?
- Over 4 years (2021 to 2025), Twist Bioscience Corporation's operating income has grown at a -2.8% compound annual growth rate (CAGR), from -$152.73M to -$136.26M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.